Philips and Centre Hospitalier Régional Universitaire de Nancy Announce 10-Year Enterprise Informatics Agreement to Increase Efficiency and Improve Patient Care

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Centre Hospitalier Régional Universitaire (CHRU) de Nancy, a leading academic hospital in the Grand Est region of France, announced a 10-year agreement to implement Philips' IntelliSpace Enterprise Imaging Solution, including Illumeo with adaptive intelligence. CHRU de Nancy is a public health institution that provides 1.2 million consultation visits and inpatient stays each year. The agreement will enable the hospital to streamline complex medical image data management across its departments in order to enhance the delivery of care with better health outcomes and improved experiences for its patients and staff.

"As we transform to focus on delivering value in healthcare, this new enterprise informatics agreement with Philips will enable us to improve productivity, enhance collaboration between clinicians, and ultimately improve health outcomes for our patients," said Jean-Christophe Calvo, Chief Information Officer and Head of the Biomedical Department, CHRU de Nancy. "The combination of our scale and expertise in research, and their comprehensive informatics solution, will enable us to better connect people and data, as well as providing a foundation for us to leverage artificial intelligence in healthcare."

"The diagnostic value of medical imaging for the assessment of the anatomy and function of disease continues to increase, as the field evolves and new techniques emerge," said Prof. Daniel Mandry, Head of the Imaging Department for Women and Children, CHRU de Nancy. "High quality medical imaging data management is key to providing a precise diagnosis. As the amount of data we capture for each patient dramatically increases, we expect Philips Illumeo to help us improve our workflows and enhance the user experience by adapting to the clinical and user context. This will free up time for our radiologists to focus on diagnosis."

Philips IntelliSpace Enterprise Imaging Solution is a comprehensive offering designed to meet the evolving needs of healthcare providers. It includes: IntelliSpace Universal Data Manager, which enables true Enterprise Imaging by combining efficient care with comprehensive clinical data management; IntelliSpace Radiology, a clinical user interface designed to optimize the impact radiologists have on patient care; IntelliSpace Radiology Workspace, which offers intelligent workflow and collaboration tools to enhance radiologist efficiency; and Illumeo with adaptive intelligence.

"In today's rapidly changing healthcare environment, managing image data is increasingly challenging, with greater clinical demands and image data management complexity," said Calum Cunningham, Business Leader for Enterprise Diagnostic Informatics at Philips. "Our partnership with CHRU de Nancy will support the hospital’s shift towards the delivery of value based care, securely connecting patients, the care team and data across the entire health system. Today's announcement, alongside our recently-announced partnership with Lille University Hospital, demonstrates the pioneering role that health institutions in France are playing in the application of artificial intelligence in healthcare in Europe."

Philips Illumeo with adaptive intelligence expands presence into Europe

CHRU de Nancy is the first healthcare organization in Europe to deploy Philips Illumeo in routine primary diagnostic use. Separately, Philips also recently agreed a two-year research partnership with Lille University Hospital, during which time the hospital will provide insights into the ongoing benefits hospitals can experience with Illumeo, as well as investigating new enhancements for the platform.

With its portfolio of imaging systems, software and associated services, Philips is enabling the increasingly precise diagnosis and treatment of disease. By combining data from a wide range of sources and applying intelligence to that data, Philips enables providers to deliver personalized healthcare that's based on a deep understanding of the individual patient.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.

About CHRU de Nancy

CHRU de Nancy (Centre Hospitalier Régional Universitaire de Nancy) is a leading hospital in the Grand Est region of France. With more than 9,000 employees, the hospital provides acute care and support to healthcare organizations across the region. It leverages its multidisciplinary, high-quality medical expertise to treat 160,000 patients each year across all stages of life, hosting 1.2 million consultation visits and inpatient stays. With its high-performance medical and surgical departments, CHRU de Nancy is a major player in biomedical research and contributes to the training of health professionals. To support its efforts to optimize patient care, the hospital is stepping up its ambulatory capabilities and playing a leading role in the development of telemedicine.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...